


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+4.89%
+0.30%
-1.43%
+0.96%
+15.95%
INBS
Intelligent Bio Solutions
$7.89
Strengths

Earnings are forecast to grow
INBS Price Performance
$0.72 (+995.83%)
$1.15 (+586.09%)
$1.45 (+444.14%)
$1.46 (+440.41%)
INBS has Extreme risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

INBS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Revenue increase YoY
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
INBS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
INBS Street Sentiment is bullish and have positive views on the near-term outlook
Average key support and resistance price levels
What is INBS current stock price?
What are INBS stock strengths?
What is INBS Risk Level?
What is INBS market cap and volume?
What is INBS current Stock IQ?
Should I buy INBS stock right now?
Is INBS a Strong Buy right now?
What does a 'Strong Buy' rating mean for INBS?
What does a 'Strong Sell' rating mean for INBS?
What factors influence INBS's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+4.89%
+0.30%
-1.43%
+0.96%
+15.95%
INBS
Intelligent Bio Solutions
Current Price
$7.89
Stock Insights
Strengths

Earnings are forecast to grow

INBS Price Performance
$0.72 (+995.83%)
$1.15 (+586.09%)
$1.45 (+444.14%)
$1.46 (+440.41%)
INBS Analysts Opinion
INBS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Revenue increase YoY
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
INBS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
INBS Street Sentiment is bullish and have positive views on the near-term outlook
INBS has Extreme risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

Average key support and resistance price levels
INBS Stock IQ
INBS Latest Analysis
Intelligent Bio Solutions closes $10 million private placement.
Fri Jan 2, 2026
Intelligent Bio Solutions Announces Closing of $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules. Intelligent Bio Solutions Inc. (INBS or the Company) (Nasdaq: INBS) a medical technology company delivering intelligent rapid non-invasive testing solutions today announced the closing of its previously announced private placement with two healthcare focused institutional investors priced at-the-market under Nasdaq rules of 2298850 shares of common stock (or pre-funded warrants
Fri Jan 2, 2026
INBS Stock Surges 132.4% on New Manufacturing Partnership . Intelligent Bio Solutions stock jumps after a new manufacturing partnership aimed at cutting costs boosting margins and scaling production ahead of United States expansion.
Fri Jan 2, 2026
Why Intelligent Bio Solutions Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Fridays Mid-Day Session. Shares of INBS) fell sharply during Friday'.s session after the company announced plans to raise fresh capital.Intelligent Bio said it will raise $10 million through a private placement which weighed on shares following the announcement.Intelligent Bio Solutions shares dipped 19.7% to $7.65 on Friday.Here are some other stocks moving in today’.s mid-day session.
Fri Jan 2, 2026
Intelligent Bio Solutions Announces $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules. (INBS or the Company) (Nasdaq: INBS) a medical technology company delivering intelligent rapid non-invasive testing solutions today announced that it entered into a securities purchase agreement with two healthcare focused institutional investors to issue in a private placement priced at-the-market under Nasdaq rules 2298850 shares of common stock (or pre-funded warrants in lieu thereof)
Wed Dec 31, 2025
Intelligent Bio Solutions launches $10M private placement.
Wed Dec 31, 2025
Intelligent Bio Solutions stock falls after $10 million private placement.
Wed Dec 31, 2025
Intelligent Bio Solutions Stock Surges 188% On New Manufacturing Partnership . (RTTNews) - Intelligent Bio Solutions Inc. (INBS) shares jumped 187.68% trading at $11.80 up $7.70 after the company announced a new manufacturing partnership aimed at strengthening global production capabilities and improving margins.
Wed Dec 31, 2025
Intelligent Bio Stock Doubles On New Manufacturing Deal Promising Major Cost Cuts. INBS) stock is trading higher on Wednesday with a session volume of 48.13 million compared to the average volume of 34.79 thousand as per .Intelligent Bio Solutions shares are climbing with conviction. Intelligent Bio on Wednesday announced a new strategic manufacturing partnership with .The collaboration is also expected ...
Wed Dec 31, 2025
Intelligent Bio Soars Over 100% On Partnership With Syrma Johari MedTech . (RTTNews) - Shares of Intelligent Bio Solutions Inc. (INBS) more than doubled today after the medical technology company announced a strategic manufacturing partnership with Syrma Johari MedTech Ltd for its flagship Intelligent Fingerprinting Drug Screening Reader.
Wed Dec 31, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
INBS Stock trends
INBS Stock performance
INBS Stock analysis
INBS investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.